Related Experiment Video
Updated: Jan 9, 2026

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
Challenges in diagnosing common tumors at uncommon sites
Rajyalakshmi Rallapalli1, Kusa Raju Pyla1, Beulah Priscilla Maddirala1
1Department of Pathology, Rangaraya Medical College, Kakinada, India.
None:
Rare tumors are a heterogeneous group of neoplasms with low incidence and are usually difficult to diagnose. Certain tumors that are common at specific anatomical locations rarely occur at unexpected locations and cause diagnostic challenges. Although histopathology is central to the diagnosis of these lesions, as with any tumor, ancillary techniques such as immunohistochemistry and molecular studies are often essential. In addition, a multidisciplinary approach that includes clinical, radiological, and biochemical inputs plays an important role in achieving an accurate diagnosis. A total number of 10 benign and malignant neoplastic lesions at rare locations were analyzed. Immunohistochemistry was performed for the required cases. The 10 cases included were: primary nasal meningioma, malignant melanoma of the lacrimal sac, metastatic synovial sarcoma of the thyroid, malignant teratoma of the thyroid, papillary serous cystadenocarcinoma of the paratestis, leiomyoma of the testis, squamous cell carcinoma arising in an epidermoid cyst, intraarticular synovial sarcoma of the knee, Ewing sarcoma of the kidney, and primary plasmacytoma of the breast. Knowledge and awareness of these entities improve the quality of reporting in any individual case. As a group, these lesions require further studies to enhance the understanding of their pathogenesis and patient care.
More Related Videos
07:44Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device
Published on: May 2, 2025
07:50Utilization of Ultrasound Guided Tissue-directed Cellular Implantation for the Establishment of Biologically Relevant Metastatic Tumor Xenografts
Published on: May 25, 2018